Search
Iovance Biotherapeutics Inc
IOVAAdd to Watchlist
4.070USD
-0.620-13.22%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.82BMarket Cap
LossP/E TTM
IOVA Income Statement
You can find the annual or quarterly income statement of Iovance Biotherapeutics Inc here for insights into the performance and operational efficiency of Iovance Biotherapeutics Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
How do I read Iovance Biotherapeutics Inc's income statement on TradingKey?
Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.
What is the difference between quarterly and annual income statements?
A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.
What does YOY mean on the income statement page?
YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.
Which income statement metrics matter most when analyzing IOVA stock?
Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.
What was Iovance Biotherapeutics Inc's revenue at year end?
Iovance Biotherapeutics Inc reported 263.50M in revenue for fiscal year 2025, up from 164.07M in the previous year.
How much revenue did Iovance Biotherapeutics Inc report in the most recent quarter?
Iovance Biotherapeutics Inc reported 71.43M in revenue for the most recent quarter, an increase of 44.82% year over year.
What was Iovance Biotherapeutics Inc's net income for the year?
Iovance Biotherapeutics Inc posted -390.98M in net income for fiscal year 2025.
How much net income did Iovance Biotherapeutics Inc post in the last quarter?
Iovance Biotherapeutics Inc reported -79.05M in net income for the latest quarter。
What was Iovance Biotherapeutics Inc's annual operating profit?
Iovance Biotherapeutics Inc's operating income was -398.21M for fiscal year 2025.
How is EPS related to the income statement?
EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.